Why Lantheus Holdings Stock Got Thrashed on Tuesday

Radiopharmaceutical specialist Lantheus Holdings (NASDAQ: LNTH) had some news to report Tuesday morning, but the market didn't greet it warmly. Following its announcement of a fresh acquisition, investors traded out of the niche healthcare stock, leaving it with a more than 7% loss on the day. That was in contrast with the S&P 500 index, which increased by 0.9%.Well before market open that morning, Lantheus announced that it has signed a definitive agreement to acquire clinical-stage peer Evergreen Theragnostics. For its new asset, Lantheus will make an up-front cash payment of $250 million, and is to be on the hook for up to $725.5 million more if and when a series of milestone payments are earned by Evergreen. Like Lantheus, Evergreen is a highly specialized healthcare company engaged in the field of radiopharmaceuticals. These are medicines that use radioactive substances to achieve a desired effect. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool